Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03778996
Title SM-88 as Maintenance Therapy for Advanced Ewing's Sarcoma Patients and as Salvage Therapy for Sarcoma Patients (HopES)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Oncology Research Center, LLC

Ewing sarcoma



Methoxsalen + Phenytoin + Sirolimus + SM88

Age Groups: senior | child | adult
Covered Countries USA

No variant requirements are available.